Publications

5677 Results

A non-factorial analysis of a factorial Phase II trial design to evaluate single agent and combination consolidation therapies following CD19 CAR T-cell therapy for relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL): SWOG-S2114

Authors
H Li;M LeBlanc;B Hess;N Hossain;SM Smith;P Stiff;J Friedberg
Journal / Conference
Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), poster
Year
2022
Research Committee(s)
Lymphoma
Study Number(s)
S2114

Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer

Authors
S Schild;X Wang;C Bestvina;T Williams;G Masters;A Singh;T Stinchcombe;J Salama;S Wolf;T Zemla;N Duma;S Chun;A Amini;D Kozono;C Watt
Journal / Conference
Clinical Lung Cancer Jul;23(5):e317-e320
Year
2022
Research Committee(s)
Lung
PMID
PMID35613998
PMC
PMC9634857
Study Number(s)
A082002

Circulating tumor DNA (ctDNA) kinetics predict progression-free and overall survival in EGFR TKI-treated patients with EGFR-mutant NSCLC (SWOG S1403)

Authors
P Mack;J Miao;M Redman;J Moon;S Goldberg;R Herbst;M Melnick;Z Walther;F Hirsch;K Politi;K Kelly;D Gandara
Journal / Conference
Clinical Cancer Research Sep 1;28(17):3752-3760
Year
2022
Research Committee(s)
Lung
PMID
PMID35713632
PMC
PMC9444942
Study Number(s)
S1403

Lung-MAP: A Collaborative Roadmap to Improve Cancer Outcomes [Editorial]

Authors
T Leal;S Dahlberg;S Ramalingam
Journal / Conference
Journal of Clinical Oncology Jul;23(5):e317-e320
Year
2022
Research Committee(s)
Lung
PMID
PMID35658027
Study Number(s)
S1400, S1800A

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

Authors
P Goodwin;B Chen;K Gelmon;T Whelan;M Ennis;J Lemieux;J Ligibel;D Hershman;I Mayer;T Hobday;J Bliss;P Rastogi;M Rabaglio-Poretti;S Mukherjee;J Mackey;V Abramson;C Oja;R Wesolowski;A Thompson;D Rea;P Stos;L Shepherd;V Stambolic;W Parulekar
Journal / Conference
JAMA May 24;327(20):1963-1973
Year
2022
Research Committee(s)
Breast
PMID
PMID35608580
PMC
PMC9131745

Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Authors
L Korde;M Somerfield;D Hershman
Journal / Conference
JCO Oncology Practice May 20;40(15):1696-1698
Year
2022
Research Committee(s)
Breast
PMID
PMID35417251

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia

Authors
L Muffly;J Yin;S Jacobson;A Wall;E Quiroz;A Advani;S Luger;M Tallman;M Litzow;M Foster;F Appelbaum;H Erba;R Larson;T Keegan;W Stock
Journal / Conference
Blood Advances Jul 26;6(14):4085-4092
Year
2022
Research Committee(s)
Leukemia
PMID
PMID35838753
Study Number(s)
C10403

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)

Authors
S Lee;C Ma;S Zhang;F-S Ou;T Bainter;D Niedzwiecki;L Saltz;R Mayer;R Whittom;A Hantel;AB Benson;D Atienza;H Kindler;C Gross;M Irwin;J Meyerhardt;C Fuchs
Journal / Conference
Oncologist Jun 8;27(6):e494-e505
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID35641198
PMC
PMC9177101
Study Number(s)
C89803

Extranodal presentation in limited stage DLBCL as a prognostic marker in three SWOG trials S0014, S0313 and S1001 [Letter to Editor]

Authors
D Stephens;H Li;L Constine;T Fitzgerald;J Leonard;B Kahl;M LeBlanc;S Smith;JW Friedberg;D Persky
Journal / Conference
Haematologica Nov 1;107(11):2732-2736
Year
2022
Research Committee(s)
Lymphoma
PMID
PMID35833300
PMC
PMC9614528
Study Number(s)
S0014, S0313, S1001

Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer

Authors
E Van Blarigan;F Ou;T Bainter;C Fuchs;D Niedzwiecki;S Zhang;L Saltz;R Mayer;A Hantel;A Benson;D Atienza;M Messino;H Kindler;A Venook;S Ogino;H Sanoff;E Giovannucci;K Ng;J Meyerhardt
Journal / Conference
JAMA Network Open Feb 1;5(2):e220145. doi: 10.1001/jamanetworkopen.2022.0145
Year
2022
Research Committee(s)
Gastrointestinal
PMID
PMID35191970
PMC
PMC8864503
Study Number(s)
C89803